[1]
Toscano, S.; Patti, F. CSF biomarkers in multiple sclerosis: beyond neuroinflammation. Neuroimmunol. Neuroinflamm., 2021, 8, 14-41.
[2]
Califf, R.M. Biomarker definitions and their applications. Exp. Biol. Med. (Maywood), 2018, 243(3), 213-221.
[3]
Mobed, A.; Razavi, S.; Ahmadalipour, A.; Shakouri, S.K.; Koohkan, G. Biosensors in Parkinson’s disease. Clin. Chim. Acta, 2021, 518, 51-58.
[4]
Zhou, L.; Wang, M-H.; Wang, J-P.; Ye, Z-Z. Application of biosensor surface immobilization methods for aptamer. Chin. J. Anal. Chem., 2011, 39(3), 432-438.
[5]
Upashama, S.; Palia, M.; Jagannatha, B.; Lina, K.C.; Prasad, S. Electrochemical aptasensing for lifestyle and chronic disease management. Curr. Med. Chem., 2023, 30, 895-909.
[6]
Kulabhusan, P.K.; Pishva, P.; Çapkın, E.; Tambe, P.; Yüce, M. Aptamer-based emerging tools for viral biomarker detection: A focus on SARS-CoV-2. Curr. Med. Chem., 2023, 30, 910-934.
[7]
Nene, A.; Geng, S.; Zhou, W.; Yu, X.F.; Luo, H.; Ramakrishna, S. Black phosphorous aptamer-based platform for biomarker detection. Curr. Med. Chem., 2023, 30, 935-952.
[8]
Piasek, A.M.; Musolf, P.; Sobiepanek, A. Aptamer-based advances in skin cancer research. Curr. Med. Chem., 2023, 30, 953-973.
